What is granulomatous disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Granulomatous Disease?

Granulomatous disease refers to a diverse group of conditions characterized by the formation of granulomas—focal, compact collections of inflammatory cells (predominantly mononuclear cells) that develop in response to persistent non-degradable antigens or active cell-mediated hypersensitivity. 1

Two Distinct Categories

Granulomatous diseases fall into two fundamentally different categories that must not be confused:

1. Chronic Granulomatous Disease (CGD)

CGD is a rare inherited primary immunodeficiency (occurring in approximately 1:250,000 individuals) caused by defects in the NADPH oxidase system of phagocytic cells, resulting in defective intracellular killing of pathogens. 2

  • Pathophysiology: Mutations in any of the five components of NADPH oxidase prevent phagocytes from generating superoxide, leading to inability to kill certain bacteria and fungi 3, 2
  • Clinical presentation: Recurrent, life-threatening bacterial and fungal infections affecting skin, airways, lymph nodes, liver, brain, and bones 2
  • Common pathogens: Staphylococcus aureus, Aspergillus species, Burkholderia cepacia, Serratia marcescens, Salmonella species, Nocardia species, and Candida albicans 4, 2
  • Inflammatory complications: Paradoxically, CGD patients develop excessive granuloma formation and inflammatory reactions (including IBD-like colitis) due to hyper-activation of NF-κB and inflammasomes 3, 5
  • Diagnosis: Nitroblue tetrazolium (NBT) test as primary screening, followed by dihydrorhodamine (DHR) flow cytometry for confirmation 6

2. Granulomatous Disorders (General)

These encompass a broad spectrum of infectious and non-infectious conditions that share the common histological feature of granuloma formation but have entirely different etiologies than CGD. 1

Classification of Granulomatous Disorders

Infectious Causes (Must Be Excluded First)

The American Thoracic Society mandates that infectious etiologies must be systematically excluded before considering non-infectious diagnoses, as infections are the most common cause worldwide. 7

  • Tuberculosis: Produces robust, frequent necrotizing granulomas with central acellular necrosis; leading cause globally 7, 8
  • Fungal infections: Histoplasma capsulatum creates large acellular necrotizing granulomas; endemic fungi vary by geography 7, 8
  • Other infections: Syphilis, rhinoscleroma, leprosy, cat scratch fever 9

Non-Infectious Causes

Sarcoidosis

Well-formed, non-necrotizing granulomas arranged in a perilymphatic distribution (around bronchovascular bundles and pleura) with minimal surrounding lymphocytic inflammation are pathognomonic for sarcoidosis. 9, 7

  • Imaging: Bilateral hilar adenopathy with perilymphatic nodules on chest CT 9
  • Clinical features: May present as Löfgren's syndrome (bilateral hilar adenopathy with erythema nodosum and/or periarticular arthritis); lupus pernio, uveitis 9
  • Laboratory: Elevated ACE (>50% above upper limit), hypercalcemia with abnormal vitamin D metabolism 9

Hypersensitivity Pneumonitis

Poorly formed, non-necrotizing granulomas with extensive surrounding lymphocytic alveolitis in a small airway distribution (bronchioles and alveolar ducts) distinguish HP from sarcoidosis. 9, 7

  • Key difference from sarcoidosis: Uniform cellular interstitial inflammation, predominantly lymphocytic, with less compact granulomas 9

Granulomatosis with Polyangiitis (GPA)

Necrotizing granulomatous inflammation combined with vasculitis affecting small-to-medium vessels characterizes GPA. 9, 7

  • Laboratory: PR3-ANCA (proteinase-3) highly specific; Staphylococcus aureus colonization found in 72% of cases 9
  • Clinical: Upper and lower airway involvement, renal disease 9

Other Non-Infectious Causes

  • Vasculitis: ANCA-associated vasculitides, Behçet's disease 9, 1
  • Occupational: Berylliosis (mimics sarcoidosis; diagnosed by blood lymphocyte proliferation test) 9
  • Drug-induced: 5-ASA, methotrexate, anti-TNF agents (paradoxical sarcoid-like reactions) 9
  • Malignancy-related: Sarcoid-like reactions to tumors, lymphomas 9
  • Immunologic: IgG4-related disease, common variable immunodeficiency 9

Critical Diagnostic Algorithm

The American Thoracic Society recommends this stepwise approach: 7, 8

  1. Obtain tissue biopsy with special stains: Perform AFB and fungal stains on ALL specimens to exclude mycobacteria and fungi—never diagnose sarcoidosis without this step 7
  2. Assess granuloma morphology: Necrotizing vs. non-necrotizing; compact vs. poorly formed; distribution pattern 9
  3. Chest CT imaging: Evaluate for bilateral hilar adenopathy, perilymphatic nodules (sarcoidosis), cavitation (infection), small airway distribution (HP) 7, 8
  4. Targeted laboratory testing:
    • Mycobacterial: AFB smear/culture, interferon-gamma release assay 8
    • Fungal: Histoplasma antigen, fungal cultures 8
    • Sarcoidosis: Serum ACE, calcium levels 9, 8
    • Vasculitis: ANCA testing if clinically suspected 7
  5. Consider geographic/occupational exposures: Histoplasmosis (Ohio/Mississippi River valleys), TB-endemic travel, livestock exposure (brucellosis) 8

Common Pitfalls to Avoid

  • Never assume sarcoidosis without excluding infection: Necrotizing granulomas can occur in sarcoidosis variants (nodular pulmonary sarcoidosis), but infection must still be ruled out 9, 7
  • Do not confuse CGD with granulomatous disorders: CGD is a specific immunodeficiency with recurrent infections; granulomatous disorders are inflammatory conditions that form granulomas 4, 1
  • Early GPA may show non-specific findings: Initial biopsies may lack obvious vasculitis features, showing only mucosal inflammation 7
  • Drug-induced granulomas are reversible: Cessation of offending agent (anti-TNF, methotrexate, 5-ASA) with or without steroids typically resolves lesions 9

References

Research

Chronic granulomatous disease.

British medical bulletin, 2016

Research

Chronic Granulomatous Disease: a Comprehensive Review.

Clinical reviews in allergy & immunology, 2021

Research

Inflammatory Complications in Chronic Granulomatous Disease.

Journal of clinical medicine, 2024

Guideline

Chronic Granulomatous Disease Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Differential Diagnosis of Granulomatous Lung Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Distinguishing Lymphoma, Disseminated TB, Sarcoidosis, Histoplasmosis, and Brucellosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.